|
BACE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.370400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.234820E-04 |
| Normal-vs-Stage2 |
1.356830E-01 |
| Normal-vs-Stage3 |
2.301600E-01 |
| Normal-vs-Stage4 |
4.628200E-02 |
| Stage1-vs-Stage2 |
5.217200E-01 |
| Stage1-vs-Stage3 |
5.914400E-02 |
| Stage1-vs-Stage4 |
6.193200E-01 |
| Stage2-vs-Stage3 |
5.006400E-01 |
| Stage2-vs-Stage4 |
8.888400E-01 |
| Stage3-vs-Stage4 |
3.642200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.337800E-03 |
| Normal-vs-AfricanAmerican |
4.127800E-02 |
| Normal-vs-Asian |
3.096600E-03 |
| Caucasian-vs-AfricanAmerican |
4.784400E-01 |
| Caucasian-vs-Asian |
2.086000E-01 |
| AfricanAmerican-vs-Asian |
8.396400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.464450E-03 |
| Normal-vs-Female |
2.758700E-03 |
| Male-vs-Female |
2.220400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.15699999999153E-05 |
| Normal-vs-Age(41-60Yrs) |
3.925600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.792650E-01 |
| Normal-vs-Age(81-100Yrs) |
1.036160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.155800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.278040E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.578900E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.590000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.146450E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.411500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.87309999627661E-08 |
| Classical-VS-Follicular |
7.190800E-04 |
| Classical-VS-Other |
5.321200E-01 |
| Classical-VS-Normal |
1.03370000004155E-06 |
| Tall-VS-Follicular |
2.571800E-01 |
| Tall-VS-Other |
3.183000E-01 |
| Tall-VS-Normal |
3.048000E-01 |
| Follicular-VS-Other |
6.112400E-01 |
| Follicular-VS-Normal |
7.799600E-01 |
| Other-VS-Normal |
5.014000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.470400E-02 |
| Normal-vs-N1 |
6.091800E-02 |
| N0-vs-N1 |
7.648800E-01 |
|
|
